Although Dnmt3a is a de novo methyltransferase [24] and usually induces the downregulation of target genes [25], in some carcinomas, Dnmt3a and p53 are positively correlated and play an important role in disease progression [26, 27]. The gene discussed is TP53; the disease is carcinoma.